Literature DB >> 20015271

Anti-PR3 immune responses induce segmental and necrotizing glomerulonephritis.

V C Primo1, S Marusic, C C Franklin, W H Goldmann, C G Achaval, R N Smith, M A Arnaout, B Nikolic.   

Abstract

Wegener's granulomatosis (WG) is a life-threatening autoimmune vasculitis that affects lungs, kidneys and other organs. A hallmark of WG is the presence of classic anti-neutrophil cytoplasmic antibodies (c-ANCA) against self-proteinase 3 (PR3). Little is known about the role of these antibodies and PR3-specific immune responses in disease development. In this study, we demonstrate that PR3-specific autoimmune responses are pathogenic in non-obese diabetic (NOD) mice with an impaired regulatory arm of the immune response. Immunization of autoimmunity prone NOD mice with rmPR3 (recombinant mouse PR3) in complete Freund's adjuvant (CFA) resulted in high levels of c-ANCA, without detectable disease development. However, when splenocytes from these immunized mice were transferred into immunodeficient NOD-severe combined immunodeficiency (SCID) mice, the recipient mice developed vasculitis and severe segmental and necrotizing glomerulonephritis. No disease developed in NOD-SCID mice that received splenocytes from the CFA-alone-immunized donors (controls), indicating that disease development depends upon PR3-specific immune responses. In contrast to the pathology observed in NOD-SCID mice, no disease was observed when splenocytes from rmPR3-immunized C57BL/6 mice were transferred into immunodeficient C57BL/6-RAG-1(-/-) mice, suggesting that complex and probably multi-genetic factors play a role in the regulation of disease development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20015271      PMCID: PMC2819498          DOI: 10.1111/j.1365-2249.2009.04072.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  43 in total

Review 1.  ANCA are pathogenic--oh yes they are!

Authors:  Ronald J Falk; J Charles Jennette
Journal:  J Am Soc Nephrol       Date:  2002-07       Impact factor: 10.121

2.  Wegener's granulomatosis.

Authors:  J L FAHEY; E LEONARD; J CHURG; G GODMAN
Journal:  Am J Med       Date:  1954-08       Impact factor: 4.965

3.  Pathogenic role of anti-neutrophil cytoplasmic antibodies in vasculitis.

Authors:  Tanya Pankhurst; Caroline O S Savage
Journal:  Curr Opin Pharmacol       Date:  2006-02-17       Impact factor: 5.547

Review 4.  Is Wegener's granulomatosis an autoimmune disease?

Authors:  P Hewins; J W Tervaert; C O Savage; C G Kallenberg
Journal:  Curr Opin Rheumatol       Date:  2000-01       Impact factor: 5.006

5.  Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo.

Authors:  E Csernok; M Ernst; W Schmitt; D F Bainton; W L Gross
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

Review 6.  The pathogenic role of antineutrophil cytoplasmic autoantibodies.

Authors:  B H Ewert; J C Jennette; R J Falk
Journal:  Am J Kidney Dis       Date:  1991-08       Impact factor: 8.860

7.  Membrane proteinase 3 expression and ANCA-induced neutrophil activation.

Authors:  Adrian Schreiber; Friedrich C Luft; Ralph Kettritz
Journal:  Kidney Int       Date:  2004-06       Impact factor: 10.612

8.  Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo.

Authors:  Heiko Pfister; Markus Ollert; Leopold F Fröhlich; Leticia Quintanilla-Martinez; Thomas V Colby; Ulrich Specks; Dieter E Jenne
Journal:  Blood       Date:  2004-05-18       Impact factor: 22.113

9.  Rats and mice immunised with chimeric human/mouse proteinase 3 produce autoantibodies to mouse Pr3 and rat granulocytes.

Authors:  Ymke M van der Geld; Thomas Hellmark; Daina Selga; Peter Heeringa; Minke G Huitema; Pieter C Limburg; Cees G M Kallenberg
Journal:  Ann Rheum Dis       Date:  2007-07-20       Impact factor: 19.103

10.  Expression of recombinant proteinase 3, the autoantigen in Wegener's granulomatosis, in insect cells.

Authors:  Y M Van der Geld; M L F Smook; M G Huitema; M C Harmsen; P C Limburg; C G M Kallenberg
Journal:  J Immunol Methods       Date:  2002-06-01       Impact factor: 2.303

View more
  31 in total

Review 1.  Innate immune cells in the pathogenesis of primary systemic vasculitis.

Authors:  Durga Prasanna Misra; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2015-09-24       Impact factor: 2.631

2.  Induction of proteinase 3-anti-neutrophil cytoplasmic autoantibodies by proteinase 3-homologous bacterial protease in mice.

Authors:  Yong Chul Kim; Yun Sik Choi; Jehan Alam; Yun-Ji Kim; Keum Jin Baek; Jaemoon Koh; Yeong Wook Song; Doo-Hyun Chung; Youngnim Choi
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

Review 3.  Updates in ANCA-associated vasculitis.

Authors:  Christian Pagnoux
Journal:  Eur J Rheumatol       Date:  2016-01-29

4.  Broadening the translational immunology landscape.

Authors:  M Peakman
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

Review 5.  Overview of the Pathogenesis of ANCA-Associated Vasculitis.

Authors:  Hong Xiao; Peiqi Hu; Ronald J Falk; J Charles Jennette
Journal:  Kidney Dis (Basel)       Date:  2015-12-03

Review 6.  Pathogenesis of antineutrophil cytoplasmic autoantibody vasculitis.

Authors:  J Charles Jennette; Ronald J Falk; Adil H Gasim
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-05       Impact factor: 2.894

Review 7.  Vasculitis: do we know more to classify better?

Authors:  Ezgi Deniz Batu; Seza Ozen
Journal:  Pediatr Nephrol       Date:  2014-12-06       Impact factor: 3.714

Review 8.  Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis.

Authors:  J Charles Jennette; Ronald J Falk; Peiqi Hu; Hong Xiao
Journal:  Annu Rev Pathol       Date:  2013-01-24       Impact factor: 23.472

Review 9.  Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease.

Authors:  J Charles Jennette; Ronald J Falk
Journal:  Nat Rev Rheumatol       Date:  2014-07-08       Impact factor: 20.543

10.  Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3.

Authors:  Lynn A Fussner; Amber M Hummel; Darrell R Schroeder; Francisco Silva; Rodrigo Cartin-Ceba; Melissa R Snyder; Gary S Hoffman; Cees G M Kallenberg; Carol A Langford; Peter A Merkel; Paul A Monach; Philip Seo; Robert F Spiera; E William St Clair; Nadia K Tchao; John H Stone; Ulrich Specks
Journal:  Arthritis Rheumatol       Date:  2016-07       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.